# Regeneron Pharmaceuticals Inc (NASDAQ: REGN), Tarrytown, NY – FDA Inspections

Source: https://www.keypedia.com/companies/regeneron-pharmaceuticals-inc/fbb2cea0-65e4-4da9-9c5f-eea90c33a84f

> Inspection records and compliance data for Regeneron Pharmaceuticals Inc in Tarrytown, New York. 13 FDA inspections on record, last inspected December 10, 2025. Publicly traded as NASDAQ: REGN.

---

## Details

- Name: Regeneron Pharmaceuticals Inc
- FEI Number: 1000521995
- Address Line 1: 777 Old Saw Mill River Rd
- City: Tarrytown
- State: New York
- Zip Code: 10591
- Country Name: United States
- Address: 777 Old Saw Mill River Rd, Tarrytown, New York 10591, United States
- Country: United States

## Stock

- Stock ticker: REGN
- Exchange: NASDAQ
- Share price: $951.19
- Market cap: $98.4B
- Price as of: November 13, 2026

## Related Documents

- FDA Inspection 1292476 - Regeneron Pharmaceuticals Inc - 2025-12-10 — source: FDA, date: December 10, 2025
- FDA Inspection 1292476 - Regeneron Pharmaceuticals Inc - 2025-12-10 — classification: No Action Indicated (NAI), source: FDA, date: December 10, 2025
- FDA Inspection 1232732 - Regeneron Pharmaceuticals Inc - 2024-05-01 — classification: No Action Indicated (NAI), source: FDA, date: May 1, 2024
- FDA Inspection 1228712 - Regeneron Pharmaceuticals Inc - 2024-01-19 — classification: No Action Indicated (NAI), source: FDA, date: January 19, 2024
- FDA Inspection 1156180 - Regeneron Pharmaceuticals Inc - 2021-10-15 — classification: No Action Indicated (NAI), source: FDA, date: October 15, 2021
- [EIR - Regeneron Pharmaceuticals Inc - 2020-12-21](https://www.keypedia.com/records/eir/regeneron-pharmaceuticals-inc/b836a15b-1f0c-45ab-9a0f-b42f75dfc397) — source: FDA, date: December 21, 2020
- FDA Inspection 1134447 - Regeneron Pharmaceuticals Inc - 2020-12-21 — classification: No Action Indicated (NAI), source: FDA, date: December 21, 2020
- [FDA Inspection 1117465 - Regeneron Pharmaceuticals Inc - 2020-01-17](https://www.keypedia.com/records/fda_inspections/regeneron-pharmaceuticals-inc/2335ccb2-402f-4d29-9b38-9f0f2be793f0) — classification: No Action Indicated (NAI), source: FDA, date: January 17, 2020
- FDA Inspection 1068761 - Regeneron Pharmaceuticals Inc - 2018-09-17 — classification: No Action Indicated (NAI), source: FDA, date: September 17, 2018
- FDA Inspection 1067515 - Regeneron Pharmaceuticals Inc - 2018-08-10 — classification: No Action Indicated (NAI), source: FDA, date: August 10, 2018
- FDA Inspection 1057304 - Regeneron Pharmaceuticals Inc - 2018-06-18 — classification: No Action Indicated (NAI), source: FDA, date: June 18, 2018

## Related Companies

- [SUN PHARMACEUTICAL INDUSTRIES INC](https://www.keypedia.com/companies/sun-pharmaceutical-industries-inc/35896832-2f85-4257-b499-6aa39d1d5f3b)
- [Incyte Corporation](https://www.keypedia.com/companies/incyte-corporation/2f3187b3-71fc-4c7d-95bf-d829cc4eceec)
- [Medpace Inc](https://www.keypedia.com/companies/medpace-inc/e09bfcb9-1613-4cc0-8434-8913be0f770d)
- [AstraZeneca Pharmaceuticals LP](https://www.keypedia.com/companies/astrazeneca-pharmaceuticals-lp/f2e34b74-3ef4-4f39-8f6f-41eceb3bb779)
- [Sagent Pharmaceuticals](https://www.keypedia.com/companies/sagent-pharmaceuticals/9b7830c1-51dd-4d82-8287-b320eff537fd)
- [Taro Pharmaceuticals U.S.A., Inc.](https://www.keypedia.com/companies/taro-pharmaceuticals-usa-inc/05da273e-af73-473f-a144-af7c4e2972c9)
- [Eisai, Inc.](https://www.keypedia.com/companies/eisai-inc/081df088-ce18-4702-a2b3-cb4e48ebe3e4)
- [Teva Pharmaceuticals USA, Inc](https://www.keypedia.com/companies/teva-pharmaceuticals-usa-inc/16ce5163-b7e9-4f34-adce-197945dc8b53)
- [Ei LLC](https://www.keypedia.com/companies/ei-llc/88b53134-ac99-4eb2-b709-2a80a826ad7d)
- [Cody Laboratories, Inc.](https://www.keypedia.com/companies/cody-laboratories-inc/ff687af7-da97-441d-b0cd-7f20af5e87a9)

## Related Officers

- [Consumer Safety Officer at FDA](https://www.keypedia.com/people/joy-ann-p-matthias/129f51c0-e0ba-45a9-b4c3-921f0178351a)